Antimicrobial Peptides as Potential Anti-Tubercular Leads: A Concise Review
Despite being considered a public health emergency for the last 25 years, tuberculosis (TB) is still one of the deadliest infectious diseases, responsible for over a million deaths every year. The length and toxicity of available treatments and the increasing emergence of multidrug-resistant strains...
Main Authors: | Gabriel S. Oliveira, Raquel P. Costa, Paula Gomes, Maria Salomé Gomes, Tânia Silva, Cátia Teixeira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/4/323 |
Similar Items
-
Host Antimicrobial Peptides: The Promise of New Treatment Strategies against Tuberculosis
by: Javier Arranz-Trullén, et al.
Published: (2017-11-01) -
Tubercular Nodular Episcleritis: A Case Report
by: Sankalp Yadav, et al.
Published: (2015-08-01) -
Tubercular rheumatism - Poncet's disease
by: Abhinav Kumar, et al.
Published: (2021-01-01) -
Tubercular lymphadenopathy with duodenal fistula
by: Mukesh Nasa, et al.
Published: (2016-04-01) -
Characterization of Two New Multidrug-Resistant Strains of Mycobacterium smegmatis: Tools for Routine In Vitro Screening of Novel Anti-Mycobacterial Agents
by: Patrick K. Arthur, et al.
Published: (2019-01-01)